Kuantum cuts FY27 revenue target by up to 22%, defers tissue plant on debt
The papermaker now sees ₹1,400-1,500 crore in revenue for FY27, down from the ₹1,800 crore target it had previously set. Management is pausing expansion to focus on its ₹720 crore debt.
— 1 earlier story on Kuantum Papers Ltd. →What's new
- Kuantum cut FY27 revenue guidance to ₹1,400-1,500 crore from a prior target of ₹1,800 crore.
- Management capped peak revenue for FY28 at ₹1,700 crore.
- The tissue paper plant expansion has been deferred to focus on debt reduction.
Why this matters
This is a significant downward revision that changes the investment thesis. The company is hitting the brakes on growth to service a ₹720 crore debt pile, a shift from prior expansion rhetoric. The delays to the PM3 machine and digester further compress the near-term production outlook.
What we're watching
- Debt reduction progress against the ₹720 crore pile.
- Commissioning timeline for the PM3 machine and new digester.
- The pace of the pivot to specialty papers and exit from notebooks.
The full read
Kuantum Papers has quietly gutted its growth story. On its latest earnings call, management sliced FY27 revenue guidance to ₹1,400-1,500 crore from the ₹1,800 crore target it had previously set. The new FY28 peak is even lower at ₹1,700 crore. The reason is twofold: global pulp markets have shifted, and the company is choosing to manage its ₹720 crore debt over funding new capacity. That choice is concrete. The planned tissue paper plant is deferred. The PM3 machine and new digester are delayed to mid-June 2026 because of import hurdles. In return, Kuantum is pivoting to specialty papers and exiting notebooks. This is a story about a balance sheet constraining a business, not a market opportunity it is pursuing.
Questions answered
- How much did Kuantum lower its revenue guidance, and why?
- The company cut its FY27 revenue target to ₹1,400-1,500 crore from a prior ₹1,800 crore, a reduction of 15-22%. Management cited shifts in the global pulp market and a priority to manage debt.
- What happened to the planned tissue paper expansion?
- The tissue paper plant project has been deferred. Management said the company is prioritizing the stabilization of its ₹720 crore debt load over new capacity in that segment.
- What is the new peak revenue target for FY28?
- Management now expects a peak revenue potential of ₹1,700 crore for FY28, setting a lower ceiling than the original FY27 target.
- Are there any other operational delays?
- Yes. The commissioning of the PM3 paper machine and a new digester system has been pushed to mid-June 2026 due to equipment import issues.
- Is the company changing its product mix?
- Yes. Kuantum is pivoting toward high-margin specialty papers and plans to exit the notebook segment entirely to improve profitability.
Story so far
All notes on KUANTUM →- 29 May 2026 · 2:15 PM IST Kuantum cuts FY27 revenue target by up to 22%, defers tissue plant on debt
- 4d ago Kuantum Papers profit drops 64% as costs erode margins